Controlled ovarian hyperstimulation with sequential letrozole co-treatment in normo/high responders
Authors:
- 16 November 2015
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 32 (3) , 206-209
Abstract
Objective: To investigate the effect of co-administration of letrozole in an ovarian stimulation protocol using recombinant FSH and GnRH antagonists for ICSI in normo/high responders. Methods: Computerized data of 320 antagonist ICSI/ET cycles with or without letrozole were retrospectively analyzed. In 105 cases, letrozole (5 mg/day) was started at the second day of the cycle continued for 5 days. At the second day of letrozole, gonadotropins were added. The remaining 215 cases were stimulated with recombinant FSH only. In all cases on day 6, GnRH antagonist was started. Ovarian stimulation protocols with or without letrozole were compared for cycle outcome parameters. Results: In cycles with letrozole, significantly lower gonadotropin consumption and lower peak estradiol levels were found. In cycles with letrozole, mean number of metaphase II and fertilized oocytes retrieved were significantly higher compared to cycles without letrozole. The pregnancy and clinical pregnancy rates were similar. Conclusion: Should the number of oocytes retrieved being higher in letrozole group might indicate that letrozole might contribute to successful ovarian stimulation with a lower dosage of gonadotropins. Despite the lower peak estradiol levels, pregnancy rates being similar to other group also support the idea that letrozole can contribute to normal potential of implantation.Keywords
This publication has 17 references indexed in Scilit:
- The comparision of effect of microdose GnRH-a flare-up, GnRH antagonist/aromatase inhibitor letrozole and GnRH antagonist/clomiphene citrate protocols on IVF outcomes in poor responder patientsGynecological Endocrinology, 2014
- Effectiveness of the antagonist/letrozole protocol for treating poor responders undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysisGynecological Endocrinology, 2014
- Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trialsFertility and Sterility, 2013
- Use of aromatase inhibitors in poor-responder patients receiving GnRH antagonist protocolsReproductive BioMedicine Online, 2009
- Use of letrozole in assisted reproduction: a systematic review and meta-analysisHuman Reproduction Update, 2008
- Follicular Phase Dynamics with Combined Aromatase Inhibitor and Follicle Stimulating Hormone TreatmentThe Journal of Clinical Endocrinology & Metabolism, 2007
- Aromatase Inhibitors for Ovulation InductionThe Journal of Clinical Endocrinology & Metabolism, 2006
- The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: A pilot studyFertility and Sterility, 2005
- A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary reportHuman Reproduction, 2004
- Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine inseminationFertility and Sterility, 2003